Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antig
- This topic has 0 replies, 1 voice, and was last updated 4 years, 4 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene
Viewing 1 post (of 1 total)
- The forum ‘Clinical Trials’ is closed to new topics and replies.